SecBot SecBot
6-K ·Filed Nov 10, 2026

GMAB

GENMAB A/S
NEUTRAL
Impact 2/10
Horizonimmediate Processed6d 7h ago SEC0001434265-26-000148
Notable filing: 6-K
Actionable Insight • Neutral

This is a routine employee warrant exercise with immaterial dilution. No market impact expected. Monitor upcoming quarterly results for operational updates.

DirectionNeutral
Confidencehigh
Horizonimmediate

How the stock moved after the report

⚠ Clustered NEUTRAL VIEWSTOCK BELOW ENTRY AT T+1
Entry
$53.87
T+0 close · Nov 10, 2026 · via day close
Latest settled
−3.95%
T+1 · $51.74
Vs SPY
−3.60%
α at T+1
Next horizon
T+5
tomorrow
  1. T+0 · Nov 11 $53.87entry
  2. T+1 · 5d ago −3.95%α −3.60% · $51.74
  3. T+3 · todayOpen
  4. T+5 · tomorrow Pending
  5. T+20 · in 23d Pending
  6. T+60 · in 3mo Pending

Price Chart

Loading chart...

How similar events traded

How similar events traded

See how far stocks moved after events like this one.

Subscribe for Full Access

Executive Summary

Genmab issued 164,828 new shares via employee warrant exercises, raising approximately DKK 369.7 million (about 0.26% of share capital). The filing is a routine capital increase from employee equity plans, not a primary offering or dilutive event of material size.

Key Facts

  • 164,828 new shares issued from employee warrant exercises
  • Proceeds of approximately DKK 369.7 million
  • Increase equals 0.2641% of Genmab's share capital
  • Total share capital post-increase: DKK 62,570,683 (62,570,683 shares)
  • Shares subscribed at prices ranging from DKK 1,362.5 to DKK 3,172 per share

Financial Impact

DKK 369.7 million (approximately $52 million) raised; dilution of 0.26% of outstanding shares

dilutioncash

Risk Factors

  • No material risks identified from this filing

Market Snapshot

Exchange
Nasdaq
Sector
Pharmaceutical Preparations
Analyst Consensus
80% bullish (25 analysts)

Investment Themes

Documents Analyzed

This report is based on 6 SEC documents filed with EDGAR.

DocumentAccession Number
6-K Filing (Primary)0001434265-26-000148
Document: gmab_20261110x6k.htm0001434265-26-000148
Document: 0001434265-26-000148-index-headers.html0001434265-26-000148
Document: 0001434265-26-000148-index.html0001434265-26-000148
Document: 0001434265-26-000148.txt0001434265-26-000148
Earnings Context (Synthetic; results releases only)0001434265-26-000148

Track record

31 reports on GMAB

Performance horizon

3 of 5 bullish or bearish reports moved the stock their way by T+20. Best: +91.28% at T+60 after the Aug 6, 2026 report. 5 of 7 went positive at some point.

Filters
  1. Nov 16, 2026today SC 13G/A Neutral 3/10 Entry $52.12 Now $51.57 −1.06% settles Dec 15
  2. Nov 12, 20264d ago 6-K Neutral 2/10 Entry $51.74 Now $51.57 −0.33% settles Dec 11
  3. Nov 12, 20264d ago 6-K Neutral 2/10 Entry $51.74 Now $51.57 −0.33% settles Dec 11
  4. Nov 12, 20264d ago 6-K Neutral 2/10 Entry $51.74 Now $51.57 −0.33% settles Dec 11
  5. Nov 12, 20264d ago 6-K Neutral 2/10 Entry $51.74 Now $51.57 −0.33% settles Dec 11
  6. Nov 10, 20266d ago 6-K Neutral 2/10 Viewing Entry $53.87 Now $51.57 −4.27% settles Dec 10
  7. Nov 10, 20266d ago 144 Neutral 2/10 Entry $54.07 Now $51.57 −4.62% settles Dec 9
  8. Nov 5, 202611d ago 6-K Neutral 5/10 Entry $52.74 Now $51.57 −2.22% settles Dec 4
  9. Nov 4, 202612d ago Institutional Cluster Neutral 2/10 Entry $52.74 Now $51.57 −2.22% settles Dec 4
  10. Oct 28, 202619d ago 6-K Bullish 6/10 Entry $57.29 Now $51.57 −9.98% settles Nov 25
Showing 10 of 31

US Market Status

Market Closed · Opens in 9h 1m

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers
Report published Nov 10, 2026